Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for PCI Outcomes in STEMI Patients
IRCT20181228042155N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of allopurinol in myocardial infarction (MI), sponsored by Isfahan University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
allopurinol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20181228042155N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181228042155N1.